Navigation

Diabetes - insulin pump therapy

Continuous subcutaneous insulin infusion for the treatment of diabetes (review).

Status: History
Expected date of issue: July 2008
Process: MTA
Description: Review of TA57 Diabetes (type 1) - insulin pump therapy.
Topic area:
  • Endocrine, nutritional and metabolic
  • Therapeutic procedures
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Elangovan Gajraj
Communications manager: Phil Ranson
Project manager: Christopher Feinmann
Assessment Group / Evidence Review Group: Aberdeen Health Technology Assessment Group
Top


 

Provisional schedule

Final scope published: January 2008
1st appraisal committee meeting: 10 October 2007
2nd appraisal committee meeting: 16 January 2008
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)

Manufacturers / Sponsors

  • Animas Corporation/Johnson & Johnson Medical Ltd (Animas Corporation R1000 Series)
  • Medtronic Ltd (MiniMed)
  • Roche Diagnostics Ltd ( Accu-Check Spirit, Accu-Chek D-TRONplus)
  • Smiths Medical International ( Deltec Cozmo)
  • Starbridge Systems Ltd ( Starlet)

Patient / Carer Groups

  • Diabetes UK
  • INPUT
  • Insulin Dependent Diabetes Trust
  • Insulin Pumpers UK
  • Juvenile Diabetes Research Foundation

Professional Groups

  • Association of British Clinical Diabetologists
  • British Dietetic Association
  • Royal College of Nursing
  • Royal College of Paediatrics and Child Health
  • Royal College of Physicians

Others

  • County Durham PCT
  • Department of Health
  • Kensington and Chelsea PCT
  • Welsh Assembly Government

General

  • Association of British Health-Care Industries (ABHI)
  • British National Formulary
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland
  • Comparator Manufacturers
  • Eli Lilly & Co Ltd
  • Novo Nordisk Ltd
  • Pfizer Ltd

Assessment Team

  • Aberdeen Health Technology Assessment Group
  • National Coordinating Centre for Health Technology Assessment

Associated Guideline Groups

  • National Collaborating Centre for Chronic Conditions
  • National Collaborating Centre for Women?s and Children's Health

Relevant Research Groups

  • Diabetes Research & Wellness Foundation
  • The Dose Adjustment for Normal Eating (DAFNE) Steering Group 

Top


 

Project history

Date Update
12 January 2007 Review page published.
24 January 2007 List of stakeholders published
25 January 2007 Final scope, cooments on draft scope and response to consultee and commentator comments on provisional matrix of consultees and commentators published
10 April 2008 Appeal published
Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.